Clinical trial
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00186875 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186875 |
|---|---|
| Title | Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia |
| Official title | A Study of Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia, Lymphoma, Lymphoblastic |
| Intervention type | Drug, Procedure |
| Interventions | Etoposide, cytarabine, vincristine, dexamethasone, methotrexate, teniposide, PEG-asparaginase, mitoxantrone, cyclophosphamide, mercaptopurine and 8 more |
| Enrollment | 47 |
| Start date | Nov 1, 2003 |
| Primary completion | Aug 1, 2016 |
| Completion | Aug 1, 2016 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: